128 related articles for article (PubMed ID: 22023049)
1. Editorial: Gold derivatives as anti-cancer agents.
Raurell LR
Anticancer Agents Med Chem; 2011 Dec; 11(10):920. PubMed ID: 22023049
[No Abstract] [Full Text] [Related]
2. Phosphine-gold(I) compounds as anticancer agents: general description and mechanisms of action.
Lima JC; Rodriguez L
Anticancer Agents Med Chem; 2011 Dec; 11(10):921-8. PubMed ID: 21864238
[TBL] [Abstract][Full Text] [Related]
3. Gold(III) complexes in medicinal chemistry.
Maia PI; Deflon VM; Abram U
Future Med Chem; 2014 Sep; 6(13):1515-36. PubMed ID: 25365235
[TBL] [Abstract][Full Text] [Related]
4. Anticancer Activity of Alkynylgold(I) with P(NMe
Abas E; Espallargas N; Burbello G; Mesonero JE; Rodriguez-Dieguez A; Grasa L; Laguna M
Inorg Chem; 2019 Nov; 58(22):15536-15551. PubMed ID: 31697068
[TBL] [Abstract][Full Text] [Related]
5. Strategies for the biological evaluation of gold anticancer agents.
Fricker SP
Anticancer Agents Med Chem; 2011 Dec; 11(10):940-52. PubMed ID: 21864236
[TBL] [Abstract][Full Text] [Related]
6. Anti-cancer gold(I) phosphine complexes: Cyclic trimers and tetramers containing the P-Au-P moiety.
Reddy TS; Privér SH; Mirzadeh N; Bhargava SK
J Inorg Biochem; 2017 Oct; 175():1-8. PubMed ID: 28686996
[TBL] [Abstract][Full Text] [Related]
7. Molecular mechanisms and proposed targets for selected anticancer gold compounds.
Casini A; Messori L
Curr Top Med Chem; 2011; 11(21):2647-60. PubMed ID: 22039866
[TBL] [Abstract][Full Text] [Related]
8. Luminescent alkynyl-gold(I) coumarin derivatives and their biological activity.
Arcau J; Andermark V; Aguiló E; Gandioso A; Moro A; Cetina M; Lima JC; Rissanen K; Ott I; Rodríguez L
Dalton Trans; 2014 Mar; 43(11):4426-36. PubMed ID: 24302256
[TBL] [Abstract][Full Text] [Related]
9. Novel gold(I) complexes with 5-phenyl-1,3,4-oxadiazole-2-thione and phosphine as potential anticancer and antileishmanial agents.
Chaves JDS; Tunes LG; de J Franco CH; Francisco TM; Corrêa CC; Murta SMF; Monte-Neto RL; Silva H; Fontes APS; de Almeida MV
Eur J Med Chem; 2017 Feb; 127():727-739. PubMed ID: 27823888
[TBL] [Abstract][Full Text] [Related]
10. Metal complexes, their cellular targets and potential for cancer therapy.
Chen D; Milacic V; Frezza M; Dou QP
Curr Pharm Des; 2009; 15(7):777-91. PubMed ID: 19275642
[TBL] [Abstract][Full Text] [Related]
11. Gold(I) complexes with alkylated PTA (1,3,5-triaza-7-phosphaadamantane) phosphanes as anticancer metallodrugs.
García-Moreno E; Gascón S; Atrián-Blasco E; Rodriguez-Yoldi MJ; Cerrada E; Laguna M
Eur J Med Chem; 2014 May; 79():164-72. PubMed ID: 24732792
[TBL] [Abstract][Full Text] [Related]
12. New bipyridine gold(III) dithiocarbamate-containing complexes exerted a potent anticancer activity against cisplatin-resistant cancer cells independent of p53 status.
Altaf M; Monim-Ul-Mehboob M; Kawde AN; Corona G; Larcher R; Ogasawara M; Casagrande N; Celegato M; Borghese C; Siddik ZH; Aldinucci D; Isab AA
Oncotarget; 2017 Jan; 8(1):490-505. PubMed ID: 27888799
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and characterization of azolate gold(I) phosphane complexes as thioredoxin reductase inhibiting antitumor agents.
Galassi R; Burini A; Ricci S; Pellei M; Rigobello MP; Citta A; Dolmella A; Gandin V; Marzano C
Dalton Trans; 2012 May; 41(17):5307-18. PubMed ID: 22391922
[TBL] [Abstract][Full Text] [Related]
14. Imidazole-based phosphane gold(I) complexes as potential agents for cancer treatment: synthesis, structural studies and antitumour activity.
Kunz PC; Kassack MU; Hamacher A; Spingler B
Dalton Trans; 2009 Oct; (37):7741-7. PubMed ID: 19759948
[TBL] [Abstract][Full Text] [Related]
15. A gold(I) phosphine complex selectively induces apoptosis in breast cancer cells: implications for anticancer therapeutics targeted to mitochondria.
Rackham O; Nichols SJ; Leedman PJ; Berners-Price SJ; Filipovska A
Biochem Pharmacol; 2007 Oct; 74(7):992-1002. PubMed ID: 17697672
[TBL] [Abstract][Full Text] [Related]
16. A golden future in medicinal inorganic chemistry: the promise of anticancer gold organometallic compounds.
Bertrand B; Casini A
Dalton Trans; 2014 Mar; 43(11):4209-19. PubMed ID: 24225667
[TBL] [Abstract][Full Text] [Related]
17. In vitro and in vivo studies of gold(I) azolate/phosphane complexes for the treatment of basal like breast cancer.
Gambini V; Tilio M; Maina EW; Andreani C; Bartolacci C; Wang J; Iezzi M; Ferraro S; Ramadori AT; Simon OC; Pucciarelli S; Wu G; Dou QP; Marchini C; Galassi R; Amici A
Eur J Med Chem; 2018 Jul; 155():418-427. PubMed ID: 29906688
[TBL] [Abstract][Full Text] [Related]
18. Mechanistic studies on two dinuclear organogold(III) compounds showing appreciable antiproliferative properties and a high redox stability.
Gabbiani C; Casini A; Kelter G; Cocco F; Cinellu MA; Fiebig HH; Messori L
Metallomics; 2011 Dec; 3(12):1318-23. PubMed ID: 21887452
[TBL] [Abstract][Full Text] [Related]
19. Gold(i) and gold(iii) phosphine complexes: synthesis, anticancer activities towards 2D and 3D cancer models, and apoptosis inducing properties.
Srinivasa Reddy T; Privér SH; Rao VV; Mirzadeh N; Bhargava SK
Dalton Trans; 2018 Nov; 47(43):15312-15323. PubMed ID: 30187047
[TBL] [Abstract][Full Text] [Related]
20. Au20 nanocluster protected by hemilabile phosphines.
Wan XK; Lin ZW; Wang QM
J Am Chem Soc; 2012 Sep; 134(36):14750-2. PubMed ID: 22931402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
